CORD-19:775b90287b44353bee979abb0970a4666022f86d / 803915-804119 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Aggressive skin care measures (including wet/dry wraps), high-dose antihistamines, gabapentin, oral antibiotics, a onemonth trial of terbinafine, and a five-month trial of omalizumab were not efficacious.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T83367","span":{"begin":0,"end":204},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T83367","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T247","span":{"begin":0,"end":204},"obj":"Sentence"}],"attributes":[{"subj":"T247","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T4206","span":{"begin":0,"end":10},"obj":"Phenotype"}],"attributes":[{"id":"A4206","pred":"hp_id","subj":"T4206","obj":"http://purl.obolibrary.org/obo/HP_0000718"},{"subj":"T4206","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1604","span":{"begin":11,"end":15},"obj":"Body_part"}],"attributes":[{"id":"A1604","pred":"uberon_id","subj":"T1604","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"subj":"T1604","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93ad","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93c7ec"},{"id":"CORD-19-PD-HP","color":"#e1ec93"},{"id":"CORD-19-PD-UBERON","color":"#dd93ec"}]}]}}